journal
https://read.qxmd.com/read/38010897/aldolase-a-promotes-cervical-cancer-cell-radioresistance-by-regulating-the-glycolysis-and-dna-damage-after-irradiation
#61
JOURNAL ARTICLE
Junying Zhou, Ningjing Lei, Bo Qin, Mengyu Chen, Shuai Gong, Hao Sun, Luojie Qiu, Fengling Wu, Ruixia Guo, Qian Ma, Yong Li, Lei Chang
Radioresistance is the major obstacle that affects the efficacy of radiotherapy which is an important treatment for cervical cancer. By analyzing the databases, we found that aldolase A (ALDOA), which is a key enzyme in metabolic reprogramming, has a higher expression in cervical cancer patients and is associated with poor prognosis. We detected the expression of ALDOA in the constructed cervical cancer radioresistance (RR) cells by repetitive irradiation and found that it was upregulated compared to the control cells...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/38010777/mathematical-modeling-predicts-pathways-to-successful-implementation-of-combination-trail-producing-oncolytic-virus-and-pac-1-to-treat-granulosa-cell-tumors-of-the-ovary
#62
JOURNAL ARTICLE
Justin Le Sauteur-Robitaille, Powel Crosley, Mary Hitt, Adrianne L Jenner, Morgan Craig
The development of new cancer therapies requires multiple rounds of validation from in vitro and in vivo experiments before they can be considered for clinical trials. Mathematical models assist in this preclinical phase by combining experimental data with human parameters to provide guidance about potential therapeutic regimens to bring forward into trials. However, granulosa cell tumors of the ovary lack a relevant mouse model, complexifying preclinical drug development for this rare tumor. To bridge this gap, we established a mathematical model as a framework to explore the potential of using a tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-producing oncolytic vaccinia virus in combination with the chemotherapeutic agent first procaspase activating compound (PAC-1)...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/38010374/revealing-the-inhibitory-effect-of-vash1-on-ovarian-cancer-from-multiple-perspectives
#63
JOURNAL ARTICLE
Yan Li, Liang Meng, Ge Lou
The function of Vasohibin-1 ( VASH1 ) in human cancer has not been thoroughly or comprehensively examined. Here, we identified the tumor suppressor part of VASH1 across cancers, including epithelial ovarian tumors. Our study carefully contrasted the expression of VASH1 in pancancer and nontumorous tissues in a public database to explore its regulatory role in clinical prognosis, diagnosis, tumor purity, and immune cell infiltration. Next, we explored the antitumor mechanism of VASH1 through drug sensitivity, functional enrichment, and phenotypic experiments in ovarian cancer...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37981873/mirna-660-3p-inhibits-malignancy-in-glioblastoma-via-negative-regulation-of-apoc1-tgf%C3%AE-2-signaling-pathway
#64
JOURNAL ARTICLE
Zelin Yang, Liang Yang, Zhenkai Sun, Yuxi Rong, Chenglian Bai, Qiaoxiang Dong, Lin Jian
Glioblastoma as the most common and aggressive central nervous system tumor in adults. Its prognosis and therapeutic outcome are poor due to the limited understanding of its molecular mechanism. Apolipoprotein C-1 (APOC1) as a member of the apolipoprotein family that acts as a tumor promoter in various cancers. MicroRNA (miRNA) can silence gene expression and suppress tumor progression. However, the role of APOC1 and its upstream miRNA has not been explored in glioblastoma. Two glioblastoma cell lines (U87 and U251) were used to explore the role of APOC1 and its upstream miRNA-660-3p in glioblastoma tumorigenesis in vitro ...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37978903/hsa_circ_0020378-regulating-mir-339-3p-col1a1-promotes-osteosarcoma-progression
#65
JOURNAL ARTICLE
Liang Liu, Wenze Huang
Osteosarcoma is a malignant orthopedic tumor that is frequently diagnosed in the pediatric population. Several studies have summarized the functions of circular RNAs (circRNAs) in the progression of osteosarcoma. This study aimed to investigate a novel circRNA, hsa_circ_0020378 (circ_0020378), and elucidate its functions and underlying mechanisms during osteosarcoma progression. The expression levels of circ_0020378, miR-339-3p, and COL1A1 in osteosarcoma cells and tissues were determined using RT-qPCR or Western blotting...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37965924/the-efficacy-of-induction-chemotherapy-or-adjuvant-chemotherapy-added-to-concurrent-chemoradiotherapy-in-t3-4n0-1m0-nasopharyngeal-carcinoma-a-propensity-score-matched-analysis
#66
JOURNAL ARTICLE
Qiulu Zhong, Danjing Luo, Xiangde Li, Qinghua Du, Qianfu Liang, Wenqi Liu, Jian Li, Xiaodong Zhu
This research aimed to assess the effectiveness of combining induction chemotherapy (IC) or adjuvant chemotherapy (AC) with concurrent chemoradiotherapy (CCRT) in patients with T3-4N0-1M0 nasopharyngeal carcinoma (NPC). Before propensity score matching(PSM),we retrospectively collected 457 patients with T3-4N0-1M0 NPC treated with CCRT with or without IC/AC. PSM method selected 285 patients from two cohort(148 in CCRT±IC/AC group,137 in CCRT group). The 3-year overall survival(OS), locoregional relapse-free survival (LRFS) and distant metastasis-free survival (DMFS) were estimated...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37962843/higher-pd-1-tim-3-expression-on-ifn-%C3%AE-t-cells-is-associated-with-poor-prognosis-in-patients-with-acute-myeloid-leukemia
#67
JOURNAL ARTICLE
Shuxin Huang, Yujie Zhao, Wenpu Lai, Jiaxiong Tan, Xue Zheng, Xianfeng Zha, Yangqiu Li, Shaohua Chen
With the success of immune checkpoint inhibitors (ICI), such as anti- programmed death-1 (PD-1) antibody for solid tumors and lymphoma immunotherapy, a number of clinical trials with ICIs have been attempted for acute myeloid leukemia (AML) immunotherapy; however, limited clinical efficacy has been reported. This may be due to the heterogeneity of immune microenvironments and various degrees of T cell exhaustion in patients and may be involved in the IFN-γ pathway. In this study, we first characterized the percentage of PD-1+ and T cell immunoglobulin mucin-domain-containing-3 (Tim-3) +IFN-γ+ T cells in peripheral blood (PB) in AML compared with healthy individuals (HIs) by flow cytometry and further discussed the possibility of the reversal of T cell exhaustion to restore the secretion capacity of cytokines in T cells in AML based on blockade of PD-1 or Tim-3 (anti-PD-1 and anti-Tim-3 antibody) in vitro using a cytokine protein chip...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37955635/clinical-application-of-molecular-residual-disease-detection-by-circulation-tumor-dna-in-solid-cancers-and-a-comparison-of-technologies-review-article
#68
REVIEW
Qiantong Dong, Chenbin Chen, Yuanbo Hu, Weiteng Zhang, Xinxin Yang, Yingxue Qi, Chan Zhu, Xiaodong Chen, Xian Shen, Weiping Ji
Molecular residual disease (MRD), detected by circulating tumor DNA (ctDNA) can be involved in the entire process of solid tumor management, including recurrence prediction, efficacy evaluation, and risk stratification. Currently, the detection technologies are divided into two main categories, as follows: tumor-agnostic and tumor informed. Tumor-informed assay obtains mutation information by sequencing tumor tissue samples before blood MRD monitoring, followed by formulation of a personalized MRD panel. Tumor-agnostic assays are carried out using a fixed panel without the mutation information from primary tumor tissue...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37948132/nat10-promotes-the-tumorigenesis-and-progression-of-laryngeal-squamous-cell-carcinoma-through-ac4c-modification-of-foxm1-mrna
#69
JOURNAL ARTICLE
Zengpei Li, Dajun Li, Tianbin Yang, Chen Yao
Laryngeal squamous cell carcinoma (LSCC), is a prevalent malignant tumor, belongs to the category of head and neck tumors. N-acetyltransferase 10 (NAT10) can alter mRNA stability through N4- acetylcytidine (ac4C) modification. This study aimed to make an investigation into the role of NAT10-mediated ac4C modification in the malignant processes of LSCC cells. The NAT10 expression in LSCC tissues and cells was detected RT-qPCR and western blot. The ac4C dot blot was performed to detect ac4C level. Besides, the cell viability, migration, and invasion abilities were detected by CCK-8 and transwell assays...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37942533/mir-597-5p-inhibits-carcinogenesis-and-macrophage-recruitment-in-colitis-related-colorectal-cancer-via-reducing-the-expression-of-cxcl5
#70
JOURNAL ARTICLE
Shuo Li, Miao Yu, Xiuying Wang, Bingyuan Fei
Despite being the subject of multiple cancer studies, nothing is known about miR-597-5p's role in colitis-associated colorectal cancer (CAC). We intend to explore how miR-597-5p influences the growth and development of CAC. In order to construct a CAC model, mice were stimulated with azoxymethane (AOM)/dextran sulfate sodium (DSS). The in situ hybridization (ISH) and quantitative real-time polymerase chain reaction (qRT-PCR) was used for the detection of miR-597-5p expression. The protein expression of CXCL5 was determined by western blotting, immunohistochemistry and enzyme-linked immuno sorbent assay (ELISA)...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37927213/pcbp1-regulates-lifr-through-fam3c-to-maintain-breast-cancer-stem-cell-self-renewal-and-invasiveness
#71
JOURNAL ARTICLE
William S Streitfeld, Annamarie C Dalton, Breege V Howley, Philip H Howe
The poly(rC) binding protein 1 gene (PCBP1) encodes the heterogeneous nuclear ribonucleoprotein E1 (hnRNPE1), a nucleic acid-binding protein that plays a tumor-suppressive role in the mammary epithelium by regulating phenotypic plasticity and cell fate. Following the loss of PCBP1 function, the FAM3C gene (encoding the Interleukin-like EMT inducer, or "ILEI" protein) and the leukemia inhibitory factor receptor (LIFR) gene are upregulated. Interaction between FAM3C and LIFR in the extracellular space induces phosphorylation of signal transducer and activator of transcription 3 (pSTAT3)...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37917550/combination-therapy-of-niclosamide-with-gemcitabine-inhibited-cell-proliferation-and-apoptosis-via-wnt-%C3%AE-catenin-c-myc-signaling-pathway-by-inducing-%C3%AE-catenin-ubiquitination-in-pancreatic-cancer
#72
JOURNAL ARTICLE
Hyeon Woong Kang, Ju Hyun Kim, Da Eun Lee, Yun Sun Lee, Myeong Jin Kim, Hyung Sun Kim, SungSoon Fang, Bo Eun Lee, Kyung Jin Lee, Jongman Yoo, Hyo Jung Kim, Joon Seong Park
Pancreatic ductal adenocarcinoma (PDAC) is a type of cancer with high morbidity and mortality rates worldwide. Owing to a lack of therapeutic options, the overall survival rate of patients with pancreatic cancer is low. Gemcitabine has been mainly used to treat patients with pancreatic cancer, but its efficacy is limited by chemoresistance. Therefore, a novel therapeutic agent for PDAC therapy is urgently needed. An anthelminthic drug, niclosamide, has already been researched in breast, lung, colon, and pancreatic cancer as an anti-cancer purpose by re-positioning its original purpose...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37906510/acquired-resistance-to-crizotinib-in-novel-cdk14-alk-and-cltc-alk-fusions-of-alk-positive-large-b-cell-lymphoma-identified-by-next-generation-sequencing
#73
JOURNAL ARTICLE
Yuxue Xia, Lu Zhang, Wenjuan He, Huaxiong Pan, Jun Fang, Guohui Cui
Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK+ LBCL) is a rare subtype of non-Hodgkin lymphoma. ALK inhibitors are being tried to treat recurrent/refractory ALK+ LBCL. A majority of patients with ALK+ tumors respond to crizotinib, but partial cases ultimately develop resistance about a year later. Here, we report a case of ALK+ LBCL carrying a new fusion gene involving CDK14 and ALK, CLTC-ALK gene rearrangements and MTOR gene mutation. The patient had progressive disease after combination of crizotinib and chemotherapy treatment about 5...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37878417/antibody-dependent-cell-mediated-cytotoxicity-selection-pressure-induces-diverse-mechanisms-of-resistance
#74
JOURNAL ARTICLE
David J Zahavi, Rossin Erbe, Yong-Wei Zhang, Theresa Guo, Zoe X Malchiodi, Rachael Maynard, Alexander Lekan, Rosa Gallagher, Julia Wulfkuhle, Emanuel Petricoin, Sandra A Jablonski, Elana J Fertig, Louis M Weiner
Targeted monoclonal antibody therapy has emerged as a powerful therapeutic strategy for cancer. However, only a minority of patients have durable responses and the development of resistance remains a major clinical obstacle. Antibody-dependent cell-mediated cytotoxicity (ADCC) represents a crucial therapeutic mechanism of action; however, few studies have explored ADCC resistance. Using multiple in vitro models of ADCC selection pressure, we have uncovered both shared and distinct resistance mechanisms. Persistent ADCC selection pressure yielded ADCC-resistant cells that are characterized by a loss of NK cell conjugation and this shared resistance phenotype is associated with cell-line dependent modulation of cell surface proteins that contribute to immune synapse formation and NK cell function...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37862152/egr1-linc00839-sox5-axis-modulates-migration-invasion-and-gemcitabine-resistance-of-bladder-cancer-cells
#75
JOURNAL ARTICLE
Zunxian Wang, Bo Wei, Shuxia Ma
BACKGROUND: Bladder cancer is one of the most common malignant tumors of the urinary system, and its incidence is increasing worldwide. However, the underlying mechanisms that trigger migration, invasion and chemotherapy resistance are unclear. RESULTS: Bioinformatics analysis of bladder cancer cohort indicated that LINC00839 is deregulated in bladder cancer. LINC00839 was validated and highly expressed in bladder cancer patients and cell lines. In addition, LINC00839 induced the migration, invasion and Gemcitabine resistance of bladder cancer cells...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37844011/dysregulation-of-the-circ_0087502-mir-1179-tgfbr2-pathway-supports-gemcitabine-resistance-in-pancreatic-cancer
#76
JOURNAL ARTICLE
Mingliu Chen, Xinxiu Liu, Jinpeng Lu, Haiwen Teng, Chengui Yu, Yingchun Liu, Yansong Zheng
BACKGROUND: Circular RNAs (circRNAs) are a cohort of non-coding RNAs generated by back-splicing events. Accumulating evidence supports the crucial role of circRNAs in human tumorigenesis, metastasis, and chemoresistance. However, the role and mechanism of circRNA circ_0087502 in pancreatic cancer are yet unknown. METHODS: The expression and function of circ_0087502 in pancreatic cancer were investigated using qRT-PCR and cell experiments. The predicted binding between circ_0087502 and microRNA-1179 (miR-1179), and between miR-1179 and TGFBR2, were examined using reporter assays...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37831547/phase-ii-study-of-apatinib-plus-exemestane-in-estrogen-receptor-positive-human-epidermal-growth-factor-receptor-2-negative-metastatic-breast-cancer
#77
JOURNAL ARTICLE
Aihua Tan, Li Nong, Hongxue Wang, Yuxian Jia, Wuning Zhong, Fanghui Qin, Han Wang, Jing Tang, Yan Liu, Yongkui Lu
PURPOSE: Apatinib is a tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor (VEGFR)-2. This study was conducted to assess the efficacy and safety of apatinib combined with exemestane in patients with estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC). METHODS: This single-center, single-arm phase II study enrolled patients with ER+/HER2- MBC progressed on previous letrozole or anastrozole...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37800580/function-of-m-5-c-rna-methyltransferase-nop2-in-high-grade-serous-ovarian-cancer
#78
JOURNAL ARTICLE
Shimin Yang, Dongmei Zhou, Chunxiao Zhang, Jiangdong Xiang, Xiaowei Xi
RNA methyltransferase nucleolar protein p120 (NOP2), commonly referred to as NOP2/Sun RNA methyltransferase family member 1 (NSUN1), is involved in cell proliferation and is highly expressed in various cancers. However, its role in high-grade serous ovarian cancer (HGSOC) remains unclear. Our study investigated the expression of NOP2 in HGSOC tissues and normal fimbria tissues, and found that NOP2 was significantly upregulated in HGSOC tissues. Our experiments showed that NOP2 overexpression promoted cell proliferation in vivo and in vitro and increased the migration and invasion ability of HGSOC cells in vitro ...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37773733/hsa_circ_0119412-is-a-tumor-promoter-in-hepatocellular-carcinoma-by-inhibiting-mir-526b-5p-to-upregulate-stmn1
#79
JOURNAL ARTICLE
Song Wu, Tao Tang, Hongchi Zhou, Jing Huang, Xiaoliang Kang, Junli Zhang
Hepatocellular carcinoma (HCC) is always deemed a deadly malignancy worldwide. Non-coding RNAs, including circRNAs, are becoming more widely recognized as essential regulators of the malignant development of HCC. Thus, we elaborated the regulating role of hsa_circ_0119412 in HCC advancement. The qRT-PCR was done to estimate the expressions of hsa_circ_0119412, miR-526b-5p, and Stathmin 1 (STMN1) in HCC (clinical samples and cell lines), and immunoblotting was used to detect STMN1 protein level in HCC cell lines...
December 31, 2023: Cancer Biology & Therapy
https://read.qxmd.com/read/37773732/-ruangan-lidan-decoction-inhibits-the-growth-and-metastasis-of-liver-cancer-by-downregulating-mir-9-5p-and-upregulating-pdk4
#80
JOURNAL ARTICLE
Tao Si, Liyin Huang, Ting Liang, Ping Huang, Hongyu Zhang, Mingmin Zhang, Xiaoling Zhou
A growing number of studies have suggested that traditional Chinese medicine (TCM) plays an essential role in the development and occurrence of liver cancer. However, the function of Ruangan Lidan decoction (RLD) in liver cancer are not yet adequately identified and manifested, which attracted our attention. The key genes related to liver cancer and RLD and the upstream miRNAs of PDK4 were obtained based on bioinformatics analysis, followed by verification of the targeting relationship between miR-9-5p and PDK4...
December 31, 2023: Cancer Biology & Therapy
journal
journal
40099
4
5
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.